Desicorpinc
Louisville, US · Delaware corporation · 1 known investors
Find your way into Desicorpinc
DesiCorp develops advanced packaging and stabilization solutions for biopharmaceutical and therapeutic products, extending shelf-life without refrigeration to improve access in rural, remote, and emergency care settings. The company uses specialized materials and two-chambered packaging designs to preserve sensitive compounds during transport and storage in austere environments.
Founders & leadership
BJ
Brett JanisinCEO / Co-Founder
JK
Jonathan KopechekinSecretary / Co-Founder
MM
Michael MenzeinPresident / Co-Founder
JK
Jonathan KopecheckExecutive
Board
RS
Robert SaundersBoard director
Investors · 1
Reported raises · per SEC filings
Form D private placements$8.7M disclosed across 2 rounds · 2024–2026
▶$3.5MraisedJun 2026 · 12 investors · BiotechnologyRule 506(b)
▶$3.5MraisedJun 2026 · 12 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Michael MenzeExecutive Officer, Director
- Jonathan KopecheckExecutive Officer, Director
- Brett JanisExecutive Officer, Director
- Robert SaundersDirector
- Offering amount
- $6M
- Amount sold
- $3.5M
- First sale
- Mar 2026
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$5.2MraisedJan 2026 · 15 investors · BiotechnologyRule 506(b)
▶$5.2MraisedJan 2026 · 15 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Robert SaundersDirector
- Michael MenzeExecutive Officer, Director
- Jonathan KopecheckExecutive Officer, Director
- Brett JanisExecutive Officer, Director
- Offering amount
- $8M
- Amount sold
- $5.2M
- First sale
- Jul 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 3
by search overlap
Labcorp10 shared keywordsLabCorp provides diagnostic testing services and clinical trial recruitment solutions that connect patient insights to drug development for healthcare providers.
IQVIA8 shared keywordsIQVIA is a healthcare data and technology company that supports life sciences organizations in research, clinical development, and commercialization of medicines and medical solutions.
Dialectic Therapeutics6 shared keywordsDialectic Therapeutics is a clinical-stage biotechnology company developing anti-cancer drugs using its Antiapoptotic Protein Targeted Degradation (APTaD) platform, which induces cancer cells to degrade proteins such as BCL-XL. Its lead candidate, DT2216, is in Phase 1/2 trials for fibrolamellar carcinoma and platinum-resistant ovarian cancer.
Companies competing with Desicorpinc for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Desicorpinc do?
- DesiCorp develops advanced packaging and stabilization solutions for biopharmaceutical and therapeutic products, extending shelf-life without refrigeration to improve access in rural, remote, and emergency care settings. The company uses specialized materials and two-chambered packaging designs to preserve sensitive compounds during transport and storage in austere environments.
- Who founded Desicorpinc?
- Desicorpinc was founded by Brett Janis, Jonathan Kopechek, Michael Menze.
- Who are Desicorpinc's investors?
- Desicorpinc's investors include Keyhorse Capital.
- How much funding has Desicorpinc raised?
- Desicorpinc has disclosed $8.7M raised across 2 rounds.
- Where is Desicorpinc headquartered?
- Desicorpinc is headquartered in Louisville, US.